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ABSTRACT 
PLGA [Poly (lactic-co-glycolic acid)] is a one of the widely used biodegradable polymer. The extensive use of PLGA is due to 
its biocompatible properties and is also approved by FDA and European Medicine Agency in parenteral drug delivery system. 
Chitosan (CS) is also an extensively used natural polymer in the field of medicine. It has been well documented as a potential 
drug carrier due to its biocompatibility. Various reports have also suggested the role of chitosan in formulation of 
nanoparticles to increase the drug bioavailability and efficacy. The characterizations of these systems pose interesting 
analytical challenges. Fourier Transform Infrared (FTIR) technique helps to analyze the adsorption of functional groups on 
nanoparticles and also to investigate the drug polymer interactions. X-ray powder diffraction (XRD) analysis helps in 
detection of crystallinity of drugs and polymers on basis of diffraction patterns. This study investigates the characterizations 
of methotrexate (MTX) and Fluorouracil (5-FU) loaded nanoparticles of PLGA and chitosan with help of FTIR and XRD 
techniques. 
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1. INTRODUCTION 
The preformulation studies are of great importance in the 
design of a new drug formulation and its quality control. It 
helps in the assessment of compatibility between the drug 
and excipients1. In the formulation of nanoparticles various 
polymers are used and therefore their interaction with the 
drug should be assessed. The incompatibility may affect the 
chemical nature, stability and bioavailability of drug along 
with the therapeutic efficacy and safety of formulation2. 
Various techniques are used now days for the assessment 
of compatibility between drug and polymers. Fourier 
Transform Infrared (FTIR) and X-ray powder diffraction 
(XRD) are most widely used analytical techniques for the 
compatibility assessment of drug and polymers due to the 
hypothesis that same functional groups may change during 
the drug-polymer interaction. The spectrum of FTIR 
represents  the  molecular  absorption  and  transmission, 
two different  molecular structures cannot produce  the  
same  infrared   spectrum. The information can be used for 
identification of unknown drugs, polymer nature and drug 
excipient interaction along with their quality and purity. 
FTIR is preferred over dispersive or filter methods of 
infrared spectral analysis, as it is a non‐destructive 
technique3-6. XRD technique is a non‐destructive technique 
and required minimal sample. This technique is most 
commonly used for identification of crystalline material by 
their unique diffraction patterns of pharmaceutical solids 
/drugs for both scientific and drug regulatory purposes7. 
This work involves the preparation and characterization of 
MTX and 5-FU loaded PLGA and Chitosan nanoparticles 
with FTIR and XRD methods. 
2. MATERIALS AND METHODS 
2.1 Materials 
Methotrexate (MTX) was obtained as a gift sample from 
Naprod Life Sciences (Mumbai), 5- Fluorouracil (5-FU) and 
Chitosan were purchased from Himedia, India,  PLGA from 
Sigma Aldrich, India, Sodium Tripolyphosphate (TPP) and 
polysorbate-80 were procured from CDH chemicals 
Laboratory, New Delhi. All other reagents were of 
analytical grade. 
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2.2 Methods 
2.2.1 Preparation of Chitosan (CS) nanoparticles for 
MTX and 5-FU  
The preparation of CS nanoparticles is based on an ionic 
interaction between positively charged CS solution and 
negatively charged sodium tripolyphosphate (TPP) 
solution in the presences of polysorbate-80 (1% w/v) as 
re-suspending agent to prevent aggregation as reported by 
calvo et al., 19978. Chitosan was dissolved in 3% acetic 
aqueous solution at concentrations (2 mg/mL) under 
magnetic stirring at room temperature, and TPP was 
dissolved in distilled water with various concentrations 
(0.2, 0.4, 0.6, 0.8, 1.0 mg/mL) as described in Figure 1. 
 
 
Figure 1:  Schematic diagram of preparation of chitosan (CS) nanoparticles 
 
2.2.2 Preparation of PLGA nanoparticles for MTX and 
5-FU 
PLGA nanoparticles were prepared by emulsification 
sonication-solvent evaporation method as reported by 
Budhian et al., 20079. This method involves preparation of 
an organic phase consisting of polymer (PLGA) and drug 
(MTX or 5-FU) dissolved in DCM (typical volume, 5 ml) 
process represented in Figure 2. Then, resulted solution 
drop wise added to aqueous solution of surfactant. In 
presented study, Polysorbate-80, polyvinyl alcohol and 
poloxamer188 were investigated as stabilizers for the 
preparation of nanoparticles of MTX loaded PLGA 
nanoparticles by emulsification sonication-solvent 
evaporation method. 
 
 
Figure 2: Schematic diagram of preparation of PLGA by emulsification sonication-solvent evaporation method 
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2.2.3 Fourier Transform Infrared spectroscopy (FT-IR) 
analysis 
FT-IR spectra of drugs (MTX and 5-FU) were recorded 
using Shimadzu-8400, Japan FTIR spectrometer by KBr 
pellet method in the region 400 cm-1 to 4000 cm-1. Samples 
equivalent to 2 mg of drugs were mixed with potassium 
bromide (about 100 mg) in a clean glass pestle and mortar 
and were compressed to obtain a pellet. Baseline was 
corrected and the samples were scanned against a blank10.  
2.2.4 X-Ray Diffraction (XRD) analysis 
X-ray powder diffraction measurements were carried out 
on drugs using a diffractometer (FOCUS D 8, Bruker, USA). 
The results were recorded over a range of 5–50° (2θ)11 . 
3 RESULTS AND DISCUSSION  
3.1 Preparation of PLGA and Chitosan nanoparticles 
for MTX and 5-FU 
MTX and 5-FU loaded Chitosan nanoparticles were 
prepared by Ionotropic gelation. The preparation of 
nanoparticles by this technique, particle morphology can 
be modified by selecting different variables such as 
agitation speed, polymer concentration and sonication 
time. In preliminary experiments, MTX and 5-FU loaded 
chitosan nanoparticles were prepared by using different 
concentrations of TPP (0.2, 0.4, 0.6, 0.8, 1.0 mg/mL) as 
gelling counter ion agent. The size of nanoparticles 
depended upon concentration of polymer and stabilizer. 
Various formulations were prepared using these variables 
and evaluated in terms of stability of nanoparticles during 
storages. Those combination of formulations were rejected 
which showed instability and trace of aggregation of 
particles during storage. Only stable formulations were 
evaluated for FTIR and XRD studies. Selected formulation 
have particle size ranges from 282.6± 13.14 to 289.± 12.13 
in case of MTX and 219.6± 13.14 to 327.8± 17.42 in case of 
5-FU. While in case of MTX and 5-FU PLGA loaded 
nanoparticles prepared by emulsification sonication-
solvent evaporation method particle size ranges from 
160.43 ± 33.34 to 290.21 ± 15.11 for MTX and 189.43 ± 
14.34 to 310.21 ± 14.11. The morphology of particles 
depends upon type and concentration of surfactant used 
for preparation of nanoparticles.  
3.2 Fourier Transform Infrared Spectroscopy (FTIR)  
Infrared spectroscopy is an essential and crucial 
characterization technique to elucidate the structure 
chemical composition and the bonding arrangement of 
constituents in polymeric materials. IR spectrum of distinct 
functional groups of MTX, 5-FU, PLGA, Chitosan, physical 
mixture and drug loaded nanoparticles exhibits molecular 
vibrations of functional groups as shown in Figures 3a-3c 
as illustrated in Table 1 and main functional groups listed 
in Table 2a-2d. The FTIR spectra of MTX characteristic 
absorption band appeared at wave numbers 3390.63 cm-1 
(-NH stretch), 1681.81 cm-1 (-COOH), 1647.1 cm-1 (-CONH), 
854.2 cm-1 (Aromatic stretch out- of- plane bend). While in 
case of 5-FU absorption bands in the region of 3000-2900 
cm−1 represents C-H stretching, bands in the region 1429-
1660 cm−1 represents the C=N and C=C ring stretching 
vibrations. The bands at about 1348.15 cm−1 were 
vibration of the pyrimidine compound; bands at 1182.28 
cm−1 and 1245.15 cm−1 were assigned to the C-O and C-N 
vibrations, respectively. Other absorption peaks includes 
3137.97 cm-1 (-NH Stretch), 1722.31 cm-1 and 1658.67 cm-1 
(-C=O Stretch), 1245.15 cm-1 (CH in Plane deformation), 
813.9 cm-1 (CH out of plane deformation). 
In case of chitosan, the characteristic absorption band 
appeared at 1589.23 cm-1, which is represented the 
stretching vibration of amino group of chitosan. Another 
band at 3413.77 cm-1 is due to amine NH symmetric 
vibration.
  
Table 1: Summarize peaks of FTIR spectra of Drugs (MTX, 5-FU), polymer (PLGA, Chitosan) and nanoparticles 
formulations 
MTX 5-FU CS PLGA MTX 
PLGA  
NPs 
MTX 
PLGA 
Physical 
Mix 
5-FU  
PLGA  
NPs 
5-FU  
PLGA  
Physical 
Mix 
CS-MTX 
NPs 
CS-MTX 
Physical 
Mix 
CS-FU 
NPs 
CS-FU 
Mix 
3411.84 3137.97 3436.91 3541.06 2935.46 3460.06 3411.12 2829.38 3402.27 2351.23 3400.27 1986.54 
3390.63 3066.61 3413.77 2997.17 2360.71 3066.61 3390.11 1986.54 1733.89 1681.1 3284.55 1893.97 
3363.62 3028.6 2875.67 2948.96 1674.1 2918.1 2829.2 1893.97 1647.1 1645.17 2725.23 1724.24 
2935.46 2999.1 2362.64 2117 1647.1 2358.78 2362.56 1650.95 1419.51 1600.81 2339.49 750.26 
2358.78 2931.6 1670.24 1758 1463.87 2329.85 1681.81 1504.37 1282.57 1494.73 1737.74 642.25 
1681.81 2885.31 1589.23 1625 1456.16 2262.35 1647.1 1448.44 1080.06 1207.36 1650.95 1658.67 
1647.1 2829.38 1157.21 1456.16 1085.85 1683.74 1602.74 1429.15 1018.34 1099.35 1417.58 1245.93 
1600.81 1986.54 1024.13 1394.44 1022.2 1647.1 1541.2 1429.15 929.63 831.26 1348.15 1429.15 
1496.66 1722.31 989.41 1384.79 931.55 1600.81 1496.66 1348.15 881.41 767.62 1280.65 1348.15 
1207.36 1670.24 892.98 1276.79 889.12 1496.66 1448.44 1245.93 864.05 578.6 1259.43 995.2 
854.2 1658.67 669.25 1182.28 873.69 1404.08 1330.79 1224.71 705.9 
 
1080.06 813.9 
831.26 1504.37 
 
1091 715.54 1207.36 1249.79 955.2 630.68 
 
881.41 
 
 
1448.44 
 
754 626.82 1099.35 1207.36 879.48 
  
630.68 
 
 
1431.08 
   
853.03 1099.35 813.9 
    
 
1348.15 
   
831.26 831.26 750.26 
    
 
1245.15 
   
767.62 767.62 642.25 
    
 
1182.28 
   
580.53 578.6 551.6 
    
 
813.9 
          MTX-Methotrexate, 5-FU-:5-Fluorouracil, PLGA-:Poly (lactide-co-glycolide), CS-Chitosan, Physical Mix-Physical mixture,  NPs: Nanoparticles 
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The peak of 2875.67 cm-1 is typical C-H vibration. The 
peaks around 892.98 and 1157.21 cm-1 correspond to 
saccharide structure of chitosan. The broad peak at 
1024.13 indicates C-O stretching vibration similar result 
reported in literature12-13. In FTIR spectra of PLGA intense 
bands observed in the region between 1770 and 1750 cm–1, 
are attributed to the stretching vibration of the carbonyl 
groups present in the two monomers. Medium intensity 
bands between 1300 and 1150 cm–1 were attributed to 
asymmetric and symmetric C-C(=O)-O stretches 
respectively. The bands in these regions are useful in the 
characterization of esters. Bands at 3500 cm–1 and 3450 
cm–1 in the FTIR spectra for lactide and glycolide are 
attributed to stretching vibrations of OH group14. The 
characteristics peaks of drugs in both the methods of 
polymeric nanoparticles were diminished or shifted when 
compared with pure drug peak at same wave number but 
not in physical mixture. This indicated that the drug is 
interacting with polymer. 
 
 
Figure 3a: FTIR spectrum of Pure MTX, 5-FU, PLGA and Chitosan 
 
Figure 3b: FTIR spectrum of Physical mixture of MTX, 5-FU, PLGA and Chitosan 
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Figure 3c: FTIR spectrum of PLGA and Chitosan NPs of MTX and 5-FU 
 
Table 2a: FTIR peaks of  functional groups of MTX 
Functional group  Corresponding bands (cm-1) 
-NH stretch 3464.82 
-COOH 1683.4 
-CONH 1645.79 
Aromatic stretch out- of- plane bend 853.588 
 
Table 2b: FTIR peaks of  functional groups of 5-FU 
Functional group  Corresponding bands (cm-1) 
C-H stretching 3000-2900 
C= N and C =C  ring stretching vibrations 1429-1660 
vibration of the pyrimidine compound 1348 
C-O 1180 
C-N 1246 
C=O Stretch 1716 cm-1 and 1657 cm-1 
CH in Plane deformation 1245 
CH out of plane deformation 813 
 
Table 2c: FTIR peaks of  functional groups of PLGA 
Functional group  Corresponding bands (cm-1) 
OH end group 3450-3500 
C-H stretches  2885- 3010   
C=O stretch 1762.6 
C-O stretch 1186-1089 
C-H Bends 1450-850 
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Table 2d: FTIR peaks of  functional groups of Chitosan 
Functional group  Corresponding bands (cm-1) 
Vibration of amino group 1589.23 
Amine NH symmetric vibration and H 
bonded O–H group  
3413.77 
C-H vibration 2875.67 
O-H, NH2 3400–3800 cm 
Saccharide antisymetric C-O stretching 900–1200 
 
3.3 X-Ray Diffraction 
X-ray diffraction was carried out to evaluate the crystalline 
character of MTX, 5-FU, PLGA, Chitosan and prepared 
nanopartilces by both methods. XRD analysis of drug, 
polymer and drug loaded nanoparticles were performed 
and illustrated in Figures 4a and 4b respectively. The 
presence of sharp and intense peaks in the diffractogram of 
Pure 5-FU indicated its crystalline nature while in case of 
MTX no sharp peaks, indicated about its amorphous in 
nature. The physical mixture of drug and drug loaded NPs 
resulted in a relatively less crystalline form and exhibited 
less intense peaks at Pure MTX shown the characteristic 
intense peaks at 2θ of approximately at 9.38, 15.6, 19.48, 
22.48, 27.02 and 32.82 and Pure 5-FU shown the 
characteristic intense peaks at 2θ of approximately at 
16.42, 20.74, 22.02, 28.82, 33 and 34.24. It was clear that 
physical mixture showed partially sharp crystalline peaks, 
representative of the characteristics of a molecular 
compound with some crystallinity, whereas a broad peak 
was presented in polymeric NPs, indicating that NPs were 
amorphous and lack crystalline peaks. A decrease in the 
intensity of the peaks was explained by a lower loading 
compared to pure drugs. Results indicating that the drugs 
were encapsulated within the NPs and suggesting that MTX 
and 5-FU in the NP matrix was molecularly dispersed or in 
the amorphous form. 
 
 
Figure 4a: X-ray diffraction pattern of Pure MTX, 5-FU, PLGA and Chitosan 
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Figure 4b: X-ray diffraction pattern of PLGA and Chitosan NPs of MTX and 5-FU 
 
4 CONCLUSION 
Drug polymer characterization studies were carried out by 
FTIR and XRD techniques for PLGA and 5-FU loaded 
nanoparticles of MTX or 5-FU. All the characteristic peaks 
and band values of FTIR studies of pure MTX or 5-FU 
compared with, physical mixture and formulated 
nanoparticles to confirm integrity of peaks. Results 
confirmed that the characteristic peaks of FTIR spectra of 
MTX and 5-FU disappeared in nanoparticles formulations 
and similar results obtained in XRD studies in which less 
intense peaks appeared for both drugs as compare to XRD 
of pure drugs. The intense peaks indicative drugs existed as 
the crystalline form which could be observed from spectra 
of alone drugs. While in case of NPs loaded formulations 
the characteristic diffraction peaks of both drugs 
disappeared, which was also revealed with results obtained 
from FTIR studies. 
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